{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T18:15:13Z","timestamp":1778696113028,"version":"3.51.4"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100016367","name":"University of Chemistry and Technology Prague","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008667","name":"National Cancer Research Institute","doi-asserted-by":"publisher","award":["LX22NPO5102"],"award-info":[{"award-number":["LX22NPO5102"]}],"id":[{"id":"10.13039\/100008667","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"Ministry of Health of the Czech Republic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014809","name":"Technology Agency of the Czech Republic","doi-asserted-by":"publisher","award":["TN02000109"],"award-info":[{"award-number":["TN02000109"]}],"id":[{"id":"10.13039\/100014809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014809","name":"Technology Agency of the Czech Republic","doi-asserted-by":"publisher","award":["LM2023052"],"award-info":[{"award-number":["LM2023052"]}],"id":[{"id":"10.13039\/100014809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001823","name":"Ministry of Education Youth and Sports of the Czech Republic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009647","name":"Ministry of Health","doi-asserted-by":"publisher","award":["NU22-08-00160"],"award-info":[{"award-number":["NU22-08-00160"]}],"id":[{"id":"10.13039\/100009647","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009647","name":"Ministry of Health","doi-asserted-by":"publisher","award":["RVO-VFN 64165"],"award-info":[{"award-number":["RVO-VFN 64165"]}],"id":[{"id":"10.13039\/100009647","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007397","name":"Univerzita Karlova v Praze","doi-asserted-by":"publisher","award":["UNCE 204064"],"award-info":[{"award-number":["UNCE 204064"]}],"id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007397","name":"Univerzita Karlova v Praze","doi-asserted-by":"publisher","award":["SVV260637"],"award-info":[{"award-number":["SVV260637"]}],"id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007397","name":"Univerzita Karlova v Praze","doi-asserted-by":"publisher","award":["SVV260521"],"award-info":[{"award-number":["SVV260521"]}],"id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.biopha.2025.118404","type":"journal-article","created":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T13:45:50Z","timestamp":1754315150000},"page":"118404","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Synthesis and evaluation of cyclobut-3-ene-1,2-dione-3-hydrazones with benzothiazole moiety as novel anticancer agents inducing nonapoptotic oncosis-like cell death"],"prefix":"10.1016","volume":"190","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3931-5010","authenticated-orcid":false,"given":"Al\u017eb\u011bta","family":"Srovnalov\u00e1","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5759-882X","authenticated-orcid":false,"given":"Robert","family":"Kapl\u00e1nek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2215-4890","authenticated-orcid":false,"given":"Zden\u011bk","family":"Kej\u00edk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3715-6626","authenticated-orcid":false,"given":"Jan","family":"Hajduch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"So\u0148a","family":"Gursk\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavel","family":"Mart\u00e1sek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mari\u00e1n","family":"Hajd\u00fach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petr","family":"D\u017eub\u00e1k","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7323-3903","authenticated-orcid":false,"given":"Milan","family":"Jakubek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.biopha.2025.118404_bib1","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.2174\/092986707781058805","article-title":"Molecular hybridization: a useful tool in the design of new drug prototypes","volume":"14","author":"Viegas-Junior","year":"2007","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.biopha.2025.118404_bib2","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ejmech.2014.03.018","article-title":"Rational approaches, design strategies, structure activity relationship and mechanistic insights for anticancer hybrids","volume":"77","author":"Nepali","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2025.118404_bib3","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ejmech.2017.07.033","article-title":"Recent advances (2015-2016) in anticancer hybrids","volume":"142","author":"Kerru","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"9","key":"10.1016\/j.biopha.2025.118404_bib4","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.2174\/1568026616666160927151144","article-title":"Dual-acting of hybrid compounds - a new Dawn in the discovery of Multi-target drugs: lead generation approaches","volume":"17","author":"Abdolmaleki","year":"2017","journal-title":"Curr. Top. Med Chem."},{"key":"10.1016\/j.biopha.2025.118404_bib5","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.biopha.2018.06.147","article-title":"A molecular approach in drug development for Alzheimer\u2019s disease","volume":"106","author":"Agatonovic-Kustrin","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2025.118404_bib6","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.3390\/ph15091071","article-title":"Concept of hybrid drugs and recent advancements in anticancer hybrids","volume":"15","author":"Singh","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/j.biopha.2025.118404_bib7","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2174\/18715206113139990312","article-title":"Benzothiazoles: how relevant in cancer drug design strategy?","volume":"14","author":"Singh","year":"2014","journal-title":"AntiCancer Agent Med. Chem."},{"issue":"2","key":"10.1016\/j.biopha.2025.118404_bib8","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1515\/hc-2013-0026","article-title":"Substituted benzothiazoles: synthesis and medicinal characteristics","volume":"19","author":"Henary","year":"2013","journal-title":"Heterocycl. Commun."},{"issue":"5","key":"10.1016\/j.biopha.2025.118404_bib9","doi-asserted-by":"crossref","first-page":"473","DOI":"10.2174\/1386207043328544","article-title":"Privileged structures: applications in drug discovery","volume":"7","author":"DeSimone","year":"2004","journal-title":"Comb. Chem. High. Throughput Screen."},{"key":"10.1016\/j.biopha.2025.118404_bib10","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ejmech.2014.10.059","article-title":"A comprehensive review in current developments of benzothiazole-based molecules in medicinal chemistry","volume":"89","author":"Keri","year":"2015","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2025.118404_bib11","first-page":"41","article-title":"Exploration of different methodologies for synthesizing biologically important benzothiazoles: an overview","volume":"13","author":"Deepak","year":"2016","journal-title":"Curr. Org. Synth."},{"issue":"3","key":"10.1016\/j.biopha.2025.118404_bib12","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1517\/13543776.2014.999764","article-title":"Therapeutic potential of benzothiazoles: a patent review (2010 - 2014)","volume":"25","author":"Kamal","year":"2015","journal-title":"Expert Opin. Ther. Pat."},{"issue":"2","key":"10.1016\/j.biopha.2025.118404_bib13","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/ddr.21753","article-title":"\"Azole\" as privileged heterocycle for targeting the inducible cyclooxygenase enzyme","volume":"82","author":"Prasher","year":"2021","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.biopha.2025.118404_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2020.213553","article-title":"Current strategies for the development of fluorescence-based molecular probes for visualizing the enzymes and proteins associated with Alzheimer\u2019s disease","volume":"427","author":"Ma","year":"2021","journal-title":"Coord. Chem. Rev."},{"issue":"23","key":"10.1016\/j.biopha.2025.118404_bib15","doi-asserted-by":"crossref","first-page":"5183","DOI":"10.1039\/C8SC01142G","article-title":"Oncosis-inducing cyclometalated iridium(iii) complexes","volume":"9","author":"Guan","year":"2018","journal-title":"Chem. Sci."},{"issue":"10","key":"10.1016\/j.biopha.2025.118404_bib16","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s00018-022-04526-5","article-title":"Potent anticancer activity of a novel iridium metallodrug via oncosis","volume":"79","author":"Ortega-Forte","year":"2022","journal-title":"Cell Mol. Life Sci."},{"issue":"1","key":"10.1016\/j.biopha.2025.118404_bib17","first-page":"3","article-title":"Apoptosis, oncosis, and necrosis. An overview of cell death","volume":"146","author":"Majno","year":"1995","journal-title":"Am. J. Pathol."},{"issue":"19","key":"10.1016\/j.biopha.2025.118404_bib18","doi-asserted-by":"crossref","first-page":"5741","DOI":"10.1016\/j.bmcl.2009.08.014","article-title":"Design, synthesis, and evaluation of novel 3-amino-4-hydrazine-cyclobut-3-ene-1,2-diones as potent and selective CXCR2 chemokine receptor antagonists","volume":"19","author":"Liu","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"4","key":"10.1016\/j.biopha.2025.118404_bib19","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1039\/c2md20011b","article-title":"Squaric acid: a valuable scaffold for developing antimalarials?","volume":"3","author":"Kumar","year":"2012","journal-title":"MedChemComm"},{"key":"10.1016\/j.biopha.2025.118404_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.130744","article-title":"Synthesis, spectral, thermal, potentiometric, antitumor, antimicrobial and PM3 studies of pyridazinone hydrazone metal complexes","volume":"1242","author":"Omar","year":"2021","journal-title":"J. Mol. Struct."},{"issue":"11","key":"10.1016\/j.biopha.2025.118404_bib21","doi-asserted-by":"crossref","first-page":"5514","DOI":"10.1039\/c1cs15119c","article-title":"New and unusual scaffolds in medicinal chemistry","volume":"40","author":"Marson","year":"2011","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.biopha.2025.118404_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112872","article-title":"Squaric acid analogues in medicinal chemistry","volume":"209","author":"Chas\u00e1k","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"20","key":"10.1016\/j.biopha.2025.118404_bib23","doi-asserted-by":"crossref","first-page":"11616","DOI":"10.1021\/acs.chemrev.0c00416","article-title":"Squaramides as bioisosteres in contemporary drug design","volume":"120","author":"Agnew-Francis","year":"2020","journal-title":"Chem. Rev."},{"issue":"6","key":"10.1016\/j.biopha.2025.118404_bib24","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.chempr.2019.02.027","article-title":"The versatility of squaramides: from supramolecular chemistry to chemical biology","volume":"5","author":"Marchetti","year":"2019","journal-title":"Chem"},{"issue":"21","key":"10.1016\/j.biopha.2025.118404_bib25","doi-asserted-by":"crossref","first-page":"8220","DOI":"10.1039\/c3cs60153f","article-title":"Be squared: expanding the horizon of squaric acid-mediated conjugations","volume":"42","author":"Wurm","year":"2013","journal-title":"Chem. Soc. Rev."},{"issue":"5","key":"10.1016\/j.biopha.2025.118404_bib26","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1039\/c0cs00200c","article-title":"Squaramides: physical properties, synthesis and applications","volume":"40","author":"Storer","year":"2011","journal-title":"Chem. Soc. Rev."},{"issue":"2","key":"10.1016\/j.biopha.2025.118404_bib27","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.carres.2007.10.015","article-title":"Preparation of glycoconjugates by dialkyl squarate chemistry revisited","volume":"343","author":"Hou","year":"2008","journal-title":"Carbohydr. Res."},{"issue":"8","key":"10.1016\/j.biopha.2025.118404_bib28","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.3390\/12081910","article-title":"Biological activities of hydrazone derivatives","volume":"12","author":"Rollas","year":"2007","journal-title":"Molecules"},{"issue":"7","key":"10.1016\/j.biopha.2025.118404_bib29","doi-asserted-by":"crossref","first-page":"971","DOI":"10.2174\/1389557511313070003","article-title":"Hydrazides\/Hydrazones as antimicrobial and anticancer agents in the new millennium","volume":"13","author":"Kumar","year":"2013","journal-title":"MiniRev. Med. Chem."},{"key":"10.1016\/j.biopha.2025.118404_bib30","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.bioorg.2015.03.003","article-title":"Caffeine-hydrazones as anticancer agents with pronounced selectivity toward T-lymphoblastic leukaemia cells","volume":"60","author":"Kaplanek","year":"2015","journal-title":"Bioorg. Chem."},{"issue":"7","key":"10.1016\/j.biopha.2025.118404_bib31","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.bmc.2015.01.029","article-title":"Synthesis and biological activity evaluation of hydrazone derivatives based on a troger's base skeleton","volume":"23","author":"Kaplanek","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.biopha.2025.118404_bib32","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ejmech.2015.11.047","article-title":"Bis-isatin hydrazones with novel linkers: synthesis and biological evaluation as cytotoxic agents","volume":"108","author":"Ibrahim","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2025.118404_bib33","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1155\/2013\/247203","article-title":"Analgesic, Anti-Inflammatory, and antiplatelet profile of hydrazones containing synthetic molecules","volume":"2013","author":"Asif","year":"2013","journal-title":"J. Appl. Chem."},{"issue":"2","key":"10.1016\/j.biopha.2025.118404_bib34","doi-asserted-by":"crossref","first-page":"76","DOI":"10.2174\/1871526515666150724104411","article-title":"Hydrazones as a privileged structural linker in antitubercular agents: a review","volume":"15","author":"Bijo","year":"2015","journal-title":"Infect. Dis. Drug Targ."},{"key":"10.1016\/j.biopha.2025.118404_bib35","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ejmech.2018.02.084","article-title":"Metallomics for alzheimer's disease treatment: use of new generation of chelators combining metal-cation binding and transport properties","volume":"150","author":"D'Acunto","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2025.118404_bib36","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejmech.2014.08.039","article-title":"Synthesis and anticancer activity of (e)-2-benzothiazole hydrazones","volume":"86","author":"Lindgren","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2025.118404_bib37","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ejmech.2015.10.041","article-title":"Synthesis of novel diflunisal hydrazide-hydrazones as anti-hepatitis c virus agents and hepatocellular carcinoma inhibitors","volume":"108","author":"Senkardes","year":"2016","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2025.118404_bib38","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/10610278.2018.1523409","article-title":"Benzoisothiazole-1,1-dioxide-based synthetic receptor for zinc ion recognition in aqueous medium and its interaction with nucleic acids","volume":"31","author":"Jakubek","year":"2019","journal-title":"Supramol. Chem."},{"key":"10.1016\/j.biopha.2025.118404_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.02.034","article-title":"Hydrazones as novel epigenetic modulators: correlation between TET 1 protein inhibition activity and their iron(II) binding ability","volume":"88","author":"Jakubek","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.biopha.2025.118404_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113736","article-title":"Azulene hydrazide-hydrazones for selective targeting of pancreatic cancer cells","volume":"155","author":"Brogy\u00e1nyi","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2025.118404_bib41","doi-asserted-by":"crossref","first-page":"10850","DOI":"10.3390\/ijms231810850","article-title":"Targeting of the mitochondrial TET1 protein by Pyrrolo[3,2-b]pyrrole chelators","volume":"23","author":"Antonyov\u00e1","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2025.118404_bib42","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0143-7208(93)85016-S","article-title":"Synthesis and characterization of unsymmetrical squaraines - a new class of cyanine dyes","volume":"21","author":"Terpetschnig","year":"1993","journal-title":"Dyes Pigments"},{"key":"10.1016\/j.biopha.2025.118404_bib43","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jlumin.2016.08.047","article-title":"Aluminium(III) sensing by pyridoxal hydrazone utilising the chelation enhanced fluorescence effect","volume":"180","author":"Kej\u00edk","year":"2016","journal-title":"J. Lumin."},{"issue":"19","key":"10.1016\/j.biopha.2025.118404_bib44","doi-asserted-by":"crossref","first-page":"14739","DOI":"10.3390\/ijms241914739","article-title":"New insights into acylhydrazones E\/Z isomerization: an experimental and theoretical approach","volume":"24","author":"Fernandez-Palacios","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"25","key":"10.1016\/j.biopha.2025.118404_bib45","doi-asserted-by":"crossref","first-page":"9812","DOI":"10.1021\/ja200699v","article-title":"Isomerization mechanism in hydrazone-based rotary switches: lateral shift, rotation, or tautomerization?","volume":"133","author":"Landge","year":"2011","journal-title":"J. Am. Chem. Soc."},{"issue":"21","key":"10.1016\/j.biopha.2025.118404_bib46","doi-asserted-by":"crossref","first-page":"3683","DOI":"10.1080\/00397910802213752","article-title":"Polystyrene-Supported iodobenzene diacetate (PSIBD)\u2013mediated synthesis of 1,2-Diacylbenzenes from 2-Hydroxyaryl Aldehyde\/Ketone acylhydrazones","volume":"38","author":"Kumar","year":"2008","journal-title":"Synth. Commun."},{"issue":"16","key":"10.1016\/j.biopha.2025.118404_bib47","doi-asserted-by":"crossref","first-page":"4908","DOI":"10.3390\/molecules26164908","article-title":"Synthesis of novel N-Acylhydrazones and their C-N\/N-N bond conformational characterization by NMR spectroscopy","volume":"26","author":"Munir","year":"2021","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.biopha.2025.118404_bib48","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1039\/D0NJ05172A","article-title":"Synthesis, photochemical isomerization and photophysical properties of hydrazide\u2013hydrazone derivatives","volume":"45","author":"Wu","year":"2021","journal-title":"New J. Chem."},{"issue":"21","key":"10.1016\/j.biopha.2025.118404_bib49","doi-asserted-by":"crossref","first-page":"6343","DOI":"10.1021\/jm060232u","article-title":"Synthesis, structure-activity relationships, and antitumor studies of 2-benzoxazolyl hydrazones derived from alpha-(N)-acyl heteroaromatics","volume":"49","author":"Easmon","year":"2006","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.biopha.2025.118404_bib50","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00044-010-9510-3","article-title":"QSAR analysis of 2-benzoxazolyl hydrazone derivatives for anticancer activity and its possible target prediction","volume":"21","author":"Moorthy","year":"2012","journal-title":"Med. Chem. Res."},{"issue":"3","key":"10.1016\/j.biopha.2025.118404_bib51","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.bmcl.2013.12.074","article-title":"Design, synthesis and biological evaluation of (e)-2-(2-arylhydrazinyl) quinoxalines, a promising and potent new class of anticancer agents","volume":"24","author":"Rodrigues","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.biopha.2025.118404_bib52","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejmech.2014.08.039","article-title":"Synthesis and anticancer activity of (e)-2-benzothiazole hydrazones","volume":"86","author":"Lindgren","year":"2014","journal-title":"Eur. J. Med. Chem."},{"issue":"1-3","key":"10.1016\/j.biopha.2025.118404_bib53","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biopha.2025.118404_bib54","unstructured":"\u3008http:\/\/www.openmolecules.org\/propertyexplorer\/applet.html\u3009."},{"issue":"24","key":"10.1016\/j.biopha.2025.118404_bib55","doi-asserted-by":"crossref","first-page":"6309","DOI":"10.3390\/ijms20246309","article-title":"ER stress induces cell cycle arrest at the G2\/M phase through eIF2alpha phosphorylation and GADD45alpha","volume":"20","author":"Lee","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2025.118404_bib56","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.cell.2007.12.033","article-title":"Visualizing spatiotemporal dynamics of multicellular cell-cycle progression","volume":"132","author":"Sakaue-Sawano","year":"2008","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.biopha.2025.118404_bib57","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/j.ajpath.2014.02.028","article-title":"Methuosis: nonapoptotic cell death associated with vacuolization of macropinosome and endosome compartments","volume":"184","author":"Maltese","year":"2014","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118404_bib58","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1177\/019262339702500116","article-title":"The pathways of cell death: oncosis, apoptosis, and necrosis","volume":"25","author":"Trump","year":"1997","journal-title":"Toxicol. Pathol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225005980?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225005980?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T17:39:10Z","timestamp":1778693950000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225005980"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":58,"alternative-id":["S0753332225005980"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118404","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and evaluation of cyclobut-3-ene-1,2-dione-3-hydrazones with benzothiazole moiety as novel anticancer agents inducing nonapoptotic oncosis-like cell death","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118404","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118404"}}